Filing Details
- Accession Number:
- 0000950170-24-026610
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 20:00:17
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 20:00:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
70318 | Tenet Healthcare Corp | THC | Services-General Medical & Surgical Hospitals, Nec (8062) | 952557091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1852128 | W Thomas Arnst | 14201 Dallas Parkway Dallas TX 75254 | Evp, Chief Admin. Officer & Gc | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-01 | 5,597 | $0.00 | 27,351 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-01 | 2,203 | $94.29 | 25,148 | No | 4 | F | Direct | |
Common Stock | Disposition | 2024-03-01 | 3,976 | $94.03 | 21,172 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-01 | 9,925 | $94.96 | 11,247 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-01 | 3,099 | $95.48 | 8,148 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 2023 March Restricted Stock Units | Acquisiton | 2024-03-01 | 5,597 | $0.00 | 5,597 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,196 | No | 4 | M | Direct |
Footnotes
- The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024.
- Restricted stock units convert into common stock on a one-for-one basis.
- Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
- Represents the closing price of the common stock of the Issuer on March 1, 2024.
- The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $93.395 to $94.39. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $94.395 to $95.37. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $95.40 to $95.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.